Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5results about How to "Protect kidney function" patented technology

A traditional Chinese medicine composition for treating diabetic nephropathy

This invention relates to a traditional Chinese medicine composition, specifically a traditional Chinese medicine composition for treating diabetic nephropathy, belonging to the fields of medicine and health products. The traditional Chinese medicine composition of this invention is made from components comprising the following raw materials: yam, salvia miltiorrhiza, rosehip, turtle shell, cornus officinalis, dioscorea hypoglauca, cuscuta chinensis, oyster shell, and American ginseng. Through rational formulation, this traditional Chinese medicine composition utilizes the principle of clearing heat and removing dampness, with the synergistic effect of multiple drugs, to significantly reduce fasting blood glucose, improve glucose metabolism, lower low-density lipoprotein cholesterol and triglycerides, and raise high-density lipoprotein cholesterol to regulate lipid metabolism, reduce weight, and has no significant damage to liver and kidney function, with minimal side effects.
Owner:DONGFANG HOSPITAL BEIJING UNIV OF CHINESE MEDICINE

Application of serum alpha-non-erythrocyte ghost protein 1 in preparation of medicine for diagnosing heart light-chain amyloidosis disease

PendingCN121955404AEnable early predictionsimplement diagnosticsBiological testingDiseaseElisa kit
The invention discloses application of serum alpha-non-red blood cell ghost protein 1 in preparation of drugs for diagnosing heart light chain amyloidosis diseases, and belongs to the technical field of biological medicines. The serum SPTAN1 protein is used for preparing the medicine for diagnosing the heart light-chain amyloidosis disease, the medicine is limited to be an enzyme linked immunosorbent assay kit, and the kit comprises an antibody of the SPTAN1 protein and further comprises a pre-coated plate, a standard substance, a coating buffer solution, a sample diluent, a confining liquid, horse radish peroxidase, an eluent and a color developing agent. The concentration of the SPTAN1 protein in the serum is measured through an enzyme linked immunosorbent assay kit, and early diagnosis of the heart AL amyloidosis disease is carried out. The invention provides a novel, efficient and sensitive biomarker, namely the serum SPTAN1 protein, early diagnosis of heart AL amyloidosis is realized by detecting the concentration of the SPTAN1 protein in serum, and the serum SPTAN1 protein has an important clinical application prospect.
Owner:ZHONGSHAN HOSPITAL FUDAN UNIV

Use of phenoxazine-1-carboxylic acid in the treatment of cisplatin-mediated acute kidney injury

PendingCN122075495ALower Damage ScoreReduce pathological damageOrganic active ingredientsNervous disorderIntraperitoneal routeInflammatory factors
The application belongs to the field of clinical drug toxic side effects, and particularly relates to the use of phenazine-1-carboxylic acid in treating cisplatin-mediated acute kidney injury. The application first discovers and proves that phenazine-1-carboxylic acid can effectively alleviate cisplatin-induced acute kidney injury. In a cisplatin-induced acute kidney injury model of mice, intraperitoneal injection of phenazine-1-carboxylic acid can effectively protect kidney function, which is specifically manifested as follows: significantly reducing urea nitrogen and creatinine levels in serum of model mice; reducing pathological injury of kidney tissue and reducing tubular injury score; and inhibiting expression of inflammatory factors and injury markers in kidney tissue. The treatment effect is equivalent to that of a classic ferroptosis inhibitor, Ferrostatin-1, and a new candidate drug for solving the dose-limiting toxicity of cisplatin in clinical application is provided.
Owner:ZHEJIANG SCI-TECH UNIV

Application of amur corktree bark extract in preparation of medicine for treating chronic nephrosis

PendingCN119607079AImprove compliance ratecontrol generationUrinary disorderPlant ingredientsLiver and kidneySide effect
According to the technical scheme, the application is characterized in that the cortex phellodendri extract is obtained by mechanically grinding cortex phellodendri chinense traditional Chinese medicinal materials into powder, carrying out reflux extraction twice by adopting 70% ethanol, and then merging the powder to obtain the cortex phellodendri chinense extract. The cortex phellodendri extract provided by the invention can effectively regulate and control kidney filtration and excretion functions, reduce the blood uric acid level, improve the standard-reaching rate of uric acid reduction, and control and improve conditions of chronic kidney diseases such as uric acid nephropathy. Compared with the existing medicine, the cortex phellodendri extract has lower liver and kidney injury risk, does not induce liver function injury after long-term use, reduces the side effect of the medicine and improves the compliance of the patient. In addition, the cortex phellodendri extract can inhibit kidney immune-inflammatory response, delay the renal fibrosis process, protect the renal function, maintain the intestinal mucosal barrier and delay the progress of chronic kidney disease to renal failure.
Owner:SICHUAN ACAD OF CHINESE MEDICINE SCI +1